ARTIVION INC (AORT) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AORT - US2289031005 - Common Stock
46.85 USD
+0.32 (+0.69%)
AORT gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. AORT has only an average score on both its financial health and profitability. AORT has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year AORT has reported negative net income.
In the past year AORT had a positive cash flow from operations.
In the past 5 years AORT always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: AORT reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of -1.06%, AORT is in the better half of the industry, outperforming 71.28% of the companies in the same industry.
The Return On Equity of AORT (-2.08%) is better than 71.81% of its industry peers.
AORT has a better Return On Invested Capital (2.28%) than 69.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.08% | ||
| ROIC | 2.28% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AORT has a Operating Margin of 5.26%. This is in the better half of the industry: AORT outperforms 70.21% of its industry peers.
In the last couple of years the Operating Margin of AORT has grown nicely.
With a decent Gross Margin value of 64.50%, AORT is doing good in the industry, outperforming 65.43% of the companies in the same industry.
In the last couple of years the Gross Margin of AORT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.26% | ||
| PM (TTM) | N/A | ||
| GM | 64.5% |
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
2. Health
2.1 Basic Checks
AORT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
AORT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AORT has more shares outstanding
AORT has a worse debt/assets ratio than last year.
2.2 Solvency
AORT has an Altman-Z score of 3.99. This indicates that AORT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.99, AORT is in the better half of the industry, outperforming 72.34% of the companies in the same industry.
AORT has a debt to FCF ratio of 12.48. This is a negative value and a sign of low solvency as AORT would need 12.48 years to pay back of all of its debts.
AORT's Debt to FCF ratio of 12.48 is fine compared to the rest of the industry. AORT outperforms 70.74% of its industry peers.
A Debt/Equity ratio of 0.50 indicates that AORT is not too dependend on debt financing.
AORT has a Debt to Equity ratio of 0.50. This is comparable to the rest of the industry: AORT outperforms 41.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 12.48 | ||
| Altman-Z | 3.99 |
ROIC/WACC0.27
WACC8.33%
2.3 Liquidity
AORT has a Current Ratio of 3.93. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
AORT has a better Current ratio (3.93) than 69.68% of its industry peers.
AORT has a Quick Ratio of 2.88. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of AORT (2.88) is better than 65.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.93 | ||
| Quick Ratio | 2.88 |
3. Growth
3.1 Past
The earnings per share for AORT have decreased strongly by -85.71% in the last year.
Looking at the last year, AORT shows a quite strong growth in Revenue. The Revenue has grown by 9.81% in the last year.
Measured over the past years, AORT shows a small growth in Revenue. The Revenue has been growing by 7.06% on average per year.
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
Revenue 1Y (TTM)9.81%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%
3.2 Future
Based on estimates for the next years, AORT will show a very strong growth in Earnings Per Share. The EPS will grow by 46.79% on average per year.
The Revenue is expected to grow by 11.19% on average over the next years. This is quite good.
EPS Next Y126.16%
EPS Next 2Y71.48%
EPS Next 3Y51.07%
EPS Next 5Y46.79%
Revenue Next Year11.67%
Revenue Next 2Y11.28%
Revenue Next 3Y11.47%
Revenue Next 5Y11.19%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
AORT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 115.82, which means the current valuation is very expensive for AORT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 64.89% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.12, AORT is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 115.82 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AORT is valued a bit cheaper than the industry average as 67.02% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, AORT is valued a bit cheaper than the industry average as 68.62% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 126.31 | ||
| EV/EBITDA | 51.74 |
4.3 Compensation for Growth
AORT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AORT's earnings are expected to grow with 51.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y71.48%
EPS Next 3Y51.07%
5. Dividend
5.1 Amount
No dividends for AORT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:AORT (11/28/2025, 12:53:07 PM)
46.85
+0.32 (+0.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners84.01%
Inst Owner ChangeN/A
Ins Owners4.41%
Ins Owner Change-5.93%
Market Cap2.21B
Revenue(TTM)422.65M
Net Income(TTM)-9.12M
Analysts83.08
Price Target52.75 (12.59%)
Short Float %3.27%
Short Ratio3.4
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1085.72%
Min EPS beat(2)243.19%
Max EPS beat(2)1928.24%
EPS beat(4)3
Avg EPS beat(4)431.47%
Min EPS beat(4)-537.25%
Max EPS beat(4)1928.24%
EPS beat(8)6
Avg EPS beat(8)226.74%
EPS beat(12)8
Avg EPS beat(12)127.86%
EPS beat(16)11
Avg EPS beat(16)63.37%
Revenue beat(2)1
Avg Revenue beat(2)0.73%
Min Revenue beat(2)-1.12%
Max Revenue beat(2)2.59%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-5.37%
Max Revenue beat(4)2.59%
Revenue beat(8)4
Avg Revenue beat(8)0.31%
Revenue beat(12)7
Avg Revenue beat(12)0.63%
Revenue beat(16)10
Avg Revenue beat(16)0.6%
PT rev (1m)18.38%
PT rev (3m)24.06%
EPS NQ rev (1m)40.81%
EPS NQ rev (3m)38%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.52%
Revenue NQ rev (1m)0.71%
Revenue NQ rev (3m)0.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 115.82 | ||
| P/S | 5.23 | ||
| P/FCF | 126.31 | ||
| P/OCF | 72.57 | ||
| P/B | 5.04 | ||
| P/tB | 79.35 | ||
| EV/EBITDA | 51.74 |
EPS(TTM)-0.26
EYN/A
EPS(NY)0.4
Fwd EY0.86%
FCF(TTM)0.37
FCFY0.79%
OCF(TTM)0.65
OCFY1.38%
SpS8.96
BVpS9.3
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.08% | ||
| ROCE | 2.88% | ||
| ROIC | 2.28% | ||
| ROICexc | 2.52% | ||
| ROICexgc | 6.11% | ||
| OM | 5.26% | ||
| PM (TTM) | N/A | ||
| GM | 64.5% | ||
| FCFM | 4.14% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y40.9%
ROICexgc growth 5Y5.66%
ROICexc growth 3Y48.24%
ROICexc growth 5Y9.09%
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
F-Score5
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 12.48 | ||
| Debt/EBITDA | 4.81 | ||
| Cap/Depr | 56.35% | ||
| Cap/Sales | 3.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 67.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.93 | ||
| Quick Ratio | 2.88 | ||
| Altman-Z | 3.99 |
F-Score5
WACC8.33%
ROIC/WACC0.27
Cap/Depr(3y)42.06%
Cap/Depr(5y)43.23%
Cap/Sales(3y)2.8%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
EPS Next Y126.16%
EPS Next 2Y71.48%
EPS Next 3Y51.07%
EPS Next 5Y46.79%
Revenue 1Y (TTM)9.81%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%
Revenue Next Year11.67%
Revenue Next 2Y11.28%
Revenue Next 3Y11.47%
Revenue Next 5Y11.19%
EBIT growth 1Y-25.58%
EBIT growth 3Y46.49%
EBIT growth 5Y14.43%
EBIT Next Year112.29%
EBIT Next 3Y43.08%
EBIT Next 5Y32.16%
FCF growth 1Y4464.09%
FCF growth 3YN/A
FCF growth 5Y7.33%
OCF growth 1Y292.01%
OCF growth 3YN/A
OCF growth 5Y7.04%
ARTIVION INC / AORT FAQ
Can you provide the ChartMill fundamental rating for ARTIVION INC?
ChartMill assigns a fundamental rating of 5 / 10 to AORT.
Can you provide the valuation status for ARTIVION INC?
ChartMill assigns a valuation rating of 4 / 10 to ARTIVION INC (AORT). This can be considered as Fairly Valued.
Can you provide the profitability details for ARTIVION INC?
ARTIVION INC (AORT) has a profitability rating of 4 / 10.
Can you provide the financial health for AORT stock?
The financial health rating of ARTIVION INC (AORT) is 6 / 10.